{% extends 'GPQuants/home.html' %}

{% block content %}
<div class="outerbox">
    <a href="{% url 'covidDataScraper' %}">Refresh the Data</a>
    <h3 class="treatmentTypeTableHeader">Top Treatments used in Trials</h3>
        <table class="treatmentTypeTable">
          
          <tr>
            <th class="covidTableHeader">Treatment</th>
            <th class="covidTableHeader">Count</th>
          </tr>
          {% for treatment in covidTreatments.treatmentTypes %}
            {% for freq in covidTreatments.treatmentTypeFreq %}
              {% if forloop.counter == forloop.parentloop.counter %}
                <tr>
                  <td class="rowData">{{ treatment }}</td>
                  <td class="rowData">{{ freq }} </td>
                </tr>
              {% endif %}
            {% endfor %}
          {% endfor %}
          
        
        </table>

        <h1 class="tableHeaderName">Drug Company Breakdown</h1>
        <table class="drugCompanyTable">
          <tr>
            <th class="drugCompanyHeader">Drug</th>
            <th class="drugCompanyHeader">Patent Holder</th>
            <th class="drugCompanyHeader">Publicly Traded Liscened Manufacterurs and Distributors</th>
          </tr>
          <tr>
            <td class="rowData">Remdesivir</td>
            <td class="rowData">Gilead Sciences (NASDAQ: <a class="stockSymbolLink" target="_blank" href="https://finance.yahoo.com/quote/GILD">GILD</a>)</td>
            <td class="rowData">Pfizer (NYSE: <a class="stockSymbolLink" target="_blank" href="https://finance.yahoo.com/quote/PFE">PFE</a>), Cipla (NSE: <a target="_blank" class="stockSymbolLink" href="https://finance.yahoo.com/quote/CIPLA.NS">CIPLA</a>), Jubilant Life Sciences (NSE: <a class="stockSymbolLink" target="_blank" href="https://finance.yahoo.com/quote/JUBILANT">JUBILANT</a>), Dr. Reddy's Laboratories (NYSE: <a class="stockSymbolLink" target="_blank" href="https://finance.yahoo.com/quote/RDY">RDY</a>), Mylan (NASDAQ: <a class="stockSymbolLink" target="_blank" href="https://finance.yahoo.com/quote/MYL">MYL</a>), Zydus Cadila Healthcare (NSE: <a href="https://finance.yahoo.com/quote/CADILAHC.NS/" class="stockSymbolLink" target="_blank">CADILAHC</a>)</td>
          </tr>
          <tr>
            <td class="rowData">Remdesivir</td>
            <td class="rowData">Gilead Sciences (NASDAQ: <a class="stockSymbolLink" target="_blank" href="https://finance.yahoo.com/quote/GILD">GILD</a>)</td>
            <td class="rowData">Pfizer (NYSE: <a class="stockSymbolLink" target="_blank" href="https://finance.yahoo.com/quote/PFE">PFE</a>), Cipla (NSE: <a target="_blank" class="stockSymbolLink" href="https://finance.yahoo.com/quote/CIPLA.NS">CIPLA</a>), Jubilant Life Sciences (NSE: <a class="stockSymbolLink" target="_blank" href="https://finance.yahoo.com/quote/JUBILANT">JUBILANT</a>), Dr. Reddy's Laboratories (NYSE: <a class="stockSymbolLink" target="_blank" href="https://finance.yahoo.com/quote/RDY">RDY</a>), Mylan (NASDAQ: <a class="stockSymbolLink" target="_blank" href="https://finance.yahoo.com/quote/MYL">MYL</a>), Zydus Cadila Healthcare (NSE: <a href="https://finance.yahoo.com/quote/CADILAHC.NS/" class="stockSymbolLink" target="_blank">CADILAHC</a>)</td>
          </tr>
          <tr>
            <td class="rowData">JAKi (baricitinib)</td>
            <td class="rowData">Novartis (NYSE: <a class="stockSymbolLink" target="_blank" href="https://finance.yahoo.com/quote/NVS">GILD</a>)</td>
            <td class="rowData">Incyte (NASDAQ: <a class="stockSymbolLink" target="_blank" href="https://finance.yahoo.com/quote/INCY">INCY</a>)</td>
          </tr>
          <tr>
            <td class="rowData">JAKi (tofacitinib)</td>
            <td class="rowData">Pfizer (NYSE: <a class="stockSymbolLink" target="_blank" href="https://finance.yahoo.com/quote/PFE">PFE</a>)</td>
            <td class="rowData">There are no liscened manufacterurs or distributors</td>
          </tr>
          <tr>
            <td class="rowData">JAKi (tofacitinib)</td>
            <td class="rowData">Pfizer (NYSE: <a class="stockSymbolLink" target="_blank" href="https://finance.yahoo.com/quote/PFE">PFE</a>)</td>
            <td class="rowData">There are no liscened manufacterurs or distributors</td>
          </tr>
          <tr>
            <td class="rowData">Sarilumab - Found innefective compared to placebo in treating COVID-19</td>
            <td class="rowData">Sanofi Pharmaceuticals (NASDAQ: <a class="stockSymbolLink" target="_blank" href="https://finance.yahoo.com/quote/SNY">SNY</a>)</td>
            <td class="rowData">Regeneron Pharmaceuticals (NASDAQ: <a class="stockSymbolLink" target="_blank" href="https://finance.yahoo.com/quote/REGN">REGN</a>)</td>
          </tr>
          <tr>
            <td class="rowData">Corticosteroids (dexamethasone)</td>
            <td class="rowData">Off-patent</td>
            <td class="rowData">Pfizer (NYSE: <a class="stockSymbolLink" target="_blank" href="https://finance.yahoo.com/quote/PFE">PFE</a>), Novartis (NYSE: <a class="stockSymbolLink" target="_blank" href="https://finance.yahoo.com/quote/NVS">NVS</a>), Merck & Co. (NYSE: <a class="stockSymbolLink" target="_blank" href="https://finance.yahoo.com/quote/MRK">MRK</a>), Sanofi Pharmaceuticals (NASDAQ: <a class="stockSymbolLink" target="_blank" href="https://finance.yahoo.com/quote/SNY">SNY</a>), Baxter International (NYSE: <a class="stockSymbolLink" target="_blank" href="https://finance.yahoo.com/quote/BAX">BAX</a>), Zydus Cadila Healthcare (NSE: <a class="stockSymbolLink" target="_blank" href="https://finance.yahoo.com/quote/CADILAHC">CADILAHC</a>), Endo International (NASDAQ: <a class="stockSymbolLink" target="_blank" href="https://finance.yahoo.com/quote/ENDP">ENDP</a>), Aspen Pahramcare (OTCMKTS: <a class="stockSymbolLink" target="_blank" href="https://finance.yahoo.com/quote/APNHY">APNHY</a>), Hikma Pharmaceuticals (OTCMKTS: <a class="stockSymbolLink" target="_blank" href="https://finance.yahoo.com/quote/HKMPF">HKMPF</a>), Cipla (NSE: <a class="stockSymbolLink" target="_blank" href="https://finance.yahoo.com/quote/CIPLA">CIPLA</a>), Wockhardt (NSE: <a class="stockSymbolLink" target="_blank" href="https://finance.yahoo.com/quote/WOCKPHARMA">WOCKPHARMA</a>)</td>
          </tr>
          <tr>
            <td class="rowData">Acalabrutinib</td>
            <td class="rowData">AstraZeneca (NYSE: <a class="stockSymbolLink" target="_blank" href="https://finance.yahoo.com/quote/AZN">AZN</a>)</td>
            <td class="rowData">There are no liscened manufacterurs or distributors</td>
          </tr>
          

        </table>

        <h1 class="tableHeaderName">Covid-19 on going Clinical Trials</h1>
        <table class="covidTrialsTable">
          <thead class="covidTrialsTableHeader">
            <tr>
              <th class="covidTableHeader">Brief Title<a class="headerColumnTooltip"><span class="headerColumnTooltipText">Lorem Ipsum</span></a></th>
              <!--<th class="covidTableHeader">Brief Summary<a class="headerColumnTooltip"><span class="headerColumnTooltipText">Lorem Ipsum</span></a></th>-->
              <th class="covidTableHeader">Study Type<a class="headerColumnTooltip">﹖<span class="headerColumnTooltipText">A type of clinical study in which participants are assigned to groups that receive one or more intervention/treatment (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes. This allows for comparison between interventions and offers a scientifically robust method of determining the safety and outcome of the intervention.</span></a></th>
              <th class="covidTableHeader">Int. / Treatment 1<a class="headerColumnTooltip">﹖<span class="headerColumnTooltipText">A process or action whose efficacy is the focus of a clinical study. Interventions include drugs, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as diet or exercise. Interventions 1 and 2 will usually be adminesteed to exclusive groups and their outcomes compared.</span></a></th>
              <th class="covidTableHeader">Int. / Treatment 2<a class="headerColumnTooltip">﹖<span class="headerColumnTooltipText">A process or action whose efficacy is the focus of a clinical study. Interventions include drugs, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as diet or exercise. Interventions 1 and 2 will usually be adminesteed to exclusive groups and their outcomes compared.</span></a></th>
              <th class="covidTableHeader">Enrollement<a class="headerColumnTooltip"><span class="headerColumnTooltipText">The target number of participants that the researchers need for the study.</span></a></th>
              <th class="covidTableHeader">Study Start Date<a class="headerColumnTooltip">﹖<span class="headerColumnTooltipText">Date that the first participant was enrolled in the study.</span></a></th>
              <th class="covidTableHeader">Est. Primary Completion Date<a class="headerColumnTooltip">﹖<span class="headerColumnTooltipText">The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure.</span></a></th>
              <th class="covidTableHeader">Est. Study Completion Date<a class="headerColumnTooltip">﹖<span class="headerColumnTooltipText">The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for secondary outcome measures and adverse events (that is, the last participant's last visit).</span></a></th>
              <th class="covidTableHeader">Arm 1 / Int. 1<a class="headerColumnTooltip">﹖<span class="headerColumnTooltipText">Lorem Ipsum</span></a></th>
              <th class="covidTableHeader">Primary Outcome Measures<a class="headerColumnTooltip">﹖<span class="headerColumnTooltipText">The most important outcome measure for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.</span></a></th>
            </tr>
          </thead>
          <tbody class="covidTrialsTableBody">
          {% for object in covidtrials %}
            <tr>
                <td class="rowData">{{ object.title }}</td>
                <!--<td class="rowData">{{ object.briefSummary }}</td>-->
                <td class="rowData">{{ object.studyType }}</td>
                <td class="rowData">{{ object.firstintervention }}</td>
                <td class="rowData">Lorem Ipsum</td>
                <td class="rowData">{{ object.enrollment }}</td>
                <td class="rowData">{{ object.startDate }}</td>
                <td class="rowData">{{ object.primaryCompletionDate }}</td>
                <td class="rowData">{{ object.studyCompletionDate }}</td>
                <td class="rowData">{{ object.armfirstintervention }}</td>
                <td class="rowData">{{ object.primaryOutcomeMes }}</td>
            </tr>
          
          {% endfor %}
          </tbody>
        </table>
                
                
        <h1 class="tableHeaderName">Covid-19 Current News Headlines involving <br>Treatments/Vaccines</h1>
            <table class="covidNewsTable">
                <tr>
                  <th class="covidTableHeader">Article Title</th>
                  <th class="covidTableHeader">Source</th>
                  <th class="covidTableHeader">Date</th>
                </tr>
                {% for object in covidHeadline %}
                
                <tr class="collapsible">
                    
                    <td class="rowData">{{ object.title }}</td>
                    <td class="rowData">{{ object.source }}</td>
                    <td class="rowData">{{ object.publishedData }}</td>
                </tr>
                
                  <tr  class="content">
                    <div  class="content">
                      <td style="border: 0px">{{ object.desc }}</td>
                      <p></p>
                    </div>

                  </tr>
                  
                
                {% endfor %}
                
              </table>

</div>
{% endblock %}
